Shultz SR

Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, VIC, Australia; Centre for Trauma and Mental Health Research, Vancouver Island University, Nanaimo, BC, Canada; School of Medical Sciences, Faculty of Health, University of Victoria, Victoria, BC, Canada; Institute on Aging & Lifelong Health, University of Victoria, Victoria, BC, Canada. Electronic address: sandy.shultz@monash.edu.

4 papers · ORCID

ArticlePsilocybin

Psilocybin restores behavior and 5-HT<sub>2A</sub> signaling while reducing microglial density after chronic traumatic brain injury in rats.

Allen J, Jupp B, Baker TL +11

Europe PMC2026
ArticlePsilocybin

Psilocybin mitigates chronic behavioral and neurobiological alterations in a rat model of recurrent intimate partner violence-related brain injury.

Allen J, Sun M, Baker TL +5

Europe PMC2026
ArticlePsilocybin

Examining the potential of psilocybin and 5-MeO-DMT as therapeutics for traumatic brain injury.

Plummer Z, Allen J, Brand J +3

Europe PMC2025
ArticlePsilocybin

Can the gut-brain axis provide insight into psilocybin's therapeutic value in reducing stress?

Kit A, Conway K, Makarowski S +5

Europe PMC2025